Abstract
Background Understanding the nature of cognitive deficits in anxiety and depression may identify intervention targets and help prevent functional decline. This study used observational and genetic methods to investigate the association of anxiety and depression with emotion recognition, response inhibition, and working memory, in young adulthood.
Methods The Avon Longitudinal Study of Parents and Children (ALSPAC) is a large prospective birth cohort study. Participants completed regular postal questionnaires and in-clinic assessments, starting from September 6, 1990. Data collection is ongoing. Linear regression was used to assess 1) cross-sectional associations between anxiety, depression, and cognition at age 24 (n = 2,187) and 2) prospective associations between anxiety and depression at age 18 and cognition at age 24 (n = 1,855). Mendelian randomization analyses were conducted to assess causal pathways between anxiety, depression, and cognition.
Results Primary analyses were conducted on 3,087 participants following multiple imputation. There was evidence for anxiety being associated with a decreased recognition of happiness (b = -0.27, 95% CI -0.54 to 0.01, p = .045), and depression being associated with an increased recognition of sadness (b = 0.35, 95% CI 0.07 to 0.64, p = .016). Anxiety was negatively associated with working memory (b = -0.14, 95% CI -0.24 to 0.04, p = .005), but no association was found for depression (b = 0.06, 95% CI -0.05 to 0.16, p = .284). There was no evidence for any association with response inhibition. Results from Mendelian randomization analyses were inconclusive, likely due to low statistical power.
Conclusions There was little evidence that anxiety and depression are associated with significant impairments in executive functioning. However, both anxiety and depression were associated with altered emotion recognition. This may inform the development of interventions that target psychosocial functioning.
Competing Interest Statement
MRM and IPV are co-directors of Jericoe Ltd, which produces software for the assessment and modification of emotion recognition. CS was employed by Cambridge Cognition during the period that this research was conducted. LM, REW and SS report no conflicts of interest.
Funding Statement
The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. A comprehensive list of grants funding is available on the ALSPAC website. GWAS data was generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. This work was undertaken with the support of the UK Medical Research Council Integrative Epidemiology Unit at the University of Bristol (MM_UU_00011/7). SS, LM, REW, IPV, and MRM are supported by the NIHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol (BRC-1215-20011). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. REW is supported by a postdoctoral fellowship from the South-Eastern Regional Health Authority (2020024). LM is supported by the Elizabeth Blackwell Institute for Health Research, University of Bristol and the Wellcome Trust Institutional Strategic Support Fund (Grant ref: 204813/Z/16/Z).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Written informed consent was obtained for the use of data collected via questionnaires and clinics from parents and participants following recommendations of the ALSPAC Ethics and Law Committee at the time. Consent for biological samples has been collected in accordance with the Human Tissue Act (2004). More details on ethics committees/institutional review boards are provided here: http://www.bristol.ac.uk/alspac/researchers/research-ethics/
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Any researcher can apply to use ALSPAC data, including the variables under investigation in this study. Access information is provided here: http://www.bristol.ac.uk/alspac/researchers/access/